A practical reference on GHRH analog: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-10-22 and is reviewed periodically as new material appears.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.
Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized white powder | Supplied as a freeze-dried solid for research use |
| Molecular weight | Approximately 3,647 Da (DAC form) | Lower for the variant lacking the albumin-binding moiety |
| Solubility | Soluble in water and aqueous buffer | Typically dissolved in sterile or bacteriostatic water |
| Typical storage temperature | −20 °C or below | Dry powder, desiccated and protected from light |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity estimation and identity confirmation |
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
=== HIV-1 === Human immunodeficiency virus-1 (HIV-1) has infected more than 60 million people worldwide. HIV-1 envelope glycoprotein contains at least four sites for neutralizing antibodies. Among these sites, the membrane-proximal region (MPR) is particularly attractive as an antibody target because it facilitates viral entry into T cells and is highly conserved among viral strains. However, it is found that two antibodies directed against 2F5, 4E10 in MPR react with self-antigens, including cardiolipin. Thus, it's difficult for such antibodies to be elicited by vaccination.
A polyamide is a polymer with repeating units linked by amide bonds. Polyamides occur both naturally and artificially. Examples of naturally occurring polyamides are proteins, such as wool and silk. Artificially made polyamides can be made through step-growth polymerization or solid-phase synthesis yielding materials such as nylons, aramids, and sodium polyaspartate. Synthetic polyamides are commonly used in textiles, automotive industry, carpets, kitchen utensils and sportswear due to their high durability and strength. The transportation manufacturing industry is the major consumer, accounting for 35% of polyamide (PA) consumption.
Gaddafi was later infuriated when Egypt and Syria planned the Yom Kippur War against Israel without consulting him and was angered when Egypt conceded to peace talks rather than continuing the war. Gaddafi became openly hostile to Egypt's leader, calling for Sadat's overthrow. When Sudanese President Gaafar Nimeiry took Sadat's side, Gaddafi also spoke out against him, encouraging the Sudan People's Liberation Army's attempt to overthrow Nimeiry. In 1974, Gaddafi released Abdul-Aziz Shennib, a commander under King Idris, from prison and appointed him Libyan ambassador to Jordan. Shennib had attended the Royal Military Academy Sandhurst with King Hussein of Jordan and was tasked by Gaddafi with Hussein's assassination. Shennib instead informed Hussein of the plot and defected to Jordan. Relations with Syria also soured over the events in the Lebanese Civil War. Initially, both Libya and Syria had contributed troops to the Arab League's peacekeeping force, although after the Syrian army attacked the Lebanese National Movement, Gaddafi openly accused Syrian President Hafez al-Assad of "national treason"; he was the only Arab leader to criticize Syria's actions. In late 1972 and early 1973, Libya invaded Chad to annex the uranium-rich Aouzou Strip. Intent on propagating Islam, in 1973 Gaddafi founded the Islamic Call Society, which had opened 132 centres across Africa within a decade. In 1973 he converted Gabonese President Omar Bongo, an action which he repeated three years later with Jean-Bédel Bokassa, president of the Central African Republic.
=== Ha–He === James Haber (b. 1943). American molecular biologist at Brandeis University known for his discoveries in the field of DNA repair. Member Natl. Acad. Sci. USA. J. B. S. Haldane (John Burdon Sanderson Haldane, 1892–1964). British (and later Indian) geneticist, biochemist (study of enzymes) and statistician, at University College London and at the end of his life at the Indian Statistical Institute. Apart from his contributions to science, he was notable for political activism and wrote many articles for the Daily Worker. Gordon Hammes (b. 1934). American biochemist at Cornell and Duke University, noted for work on enzyme mechanisms and kinetics. Member Natl. Acad. Sci. USA. Philip Handler (1917–1981). American nutritionist and biochemist, noted for the understanding of nicotinic acid deficiency and the discovery of the tryptophan-nicotinic acid relationship. He was at Duke University until he became President of the Natl. Acad. Sci. USA Jean Hanson (1919–1973). British biophysicist and zoologist at Massachusetts Institute of Technology known for her contributions to muscle research. Arthur Harden FRS (1865–1940). British biochemist at the Lister Institute, known for work on the fermentation of sugar and fermentative enzymes. Nobel Prize in Chemistry (1929). Grahame Hardie FRS (b. 1950), British biochemist at the University of Dundee, known for work on AMP-activated protein kinase. Harry Harris FRS, FCRP (1919–1994), British-born biochemist who showed that human genetic variation was not rare. Edwin B.
Sources: en.wikipedia.org
=== Australian National University === In the original design of the city of Canberra, the architect, Walter Burley Griffin, had provided for a university and had set aside land for it at the base of Black Mountain, where it would ultimately be built. Sir David Rivett chaired a committee constituted to investigate the proposed medical research institute, how much it would cost, and how it would affect existing and proposed institutions. Florey mailed Rivett a 19-page proposal on 7 April 1945. Florey envisaged a funding body in Australia similar to the Medical Research Council in the UK. The institute would be headed by a director, and have about one hundred staff, which he calculated would cost about £100,000 (equivalent to £3,732,000 in 2025). His estimate of the cost of the building was too low; Florey estimated that £240,000 (equivalent to £8,956,000 in 2025) would be enough for a building for 60 researchers, but it would eventually cost almost four times as much.
A property of DNA is its ability to re-anneal into double-stranded molecules when pH conditions are neutralized. Under neutral conditions, hydrogen bonds reform between complementary base pairs. Because the plasmid was so tightly coiled and small before the alkaline conditions were established, it can easily re-anneal. The chromosomal DNA, however, because of its lengthy strands, does not re-anneal. Once the plasmid DNA reassociates into double-stranded molecules, it dissolves into the solution. Potassium acetate reacts with the SDS detergent, magnesium ions, and calcium ions already present in the solution and forms potassium dodecyl sulfate (KDS), an insoluble white solid which precipitates out of solution. The remaining chromosomal DNA strands, denatured proteins, and added chemicals stick together and precipitate out with the KDS. The plasmid DNA, however, remains dissolved in the liquid solution. The solution is usually centrifuged to collect the insoluble precipitates into a debris pellet at the bottom of the sample tube and thereby isolate them from the supernatant.
=== Nuclear weapons === Neptunium is fissionable, and could theoretically be used as fuel in a fast-neutron reactor or a nuclear weapon, with a critical mass of around 60 kilograms. In 1992, the U.S. Department of Energy declassified the statement that neptunium-237 "can be used for a nuclear explosive device". It is not believed that an actual weapon has ever been constructed using neptunium. As of 2009, the world production of neptunium-237 by commercial power reactors was over 1000 critical masses a year, but to extract the isotope from irradiated fuel elements would be a major industrial undertaking. In September 2002, researchers at the Los Alamos National Laboratory briefly produced the first known nuclear critical mass using a significant fraction of neptunium, in combination with shells of enriched uranium (uranium-235), discovering that the critical mass of a bare sphere of neptunium-237 "ranges from kilogram weights in the high fifties to low sixties", showing that it "is about as good a bomb material as [uranium-235]". The United States Federal government made plans in March 2004 to move America's supply of separated neptunium to a nuclear-waste disposal site in Nevada.
Insulin aspart, sold under the brand name Novolog, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. It is generally used by injection under the skin (into the abdomen, buttocks, thighs, or upper arms) but may also be used by injection into a vein. Common side effects include low blood sugar, allergic reactions, itchiness, and pain at the site of injection. Other common side effects may include injection site reactions, itching, rash, lipodystrophy (skin thickening or pitting at the injection site), weight gain and swelling of hands and feet. Other serious side effects may include low blood potassium (hypokalemia), low blood sugar (hypoglycemia), and severe allergic reactions. Use in pregnancy and breastfeeding is generally safe. It works the same as human insulin by increasing the amount of glucose that tissues take in and decreasing the amount of glucose made by the liver. It is a manufactured form of human insulin; where a single amino acid has been changed, specifically a proline with an aspartic acid at the B28 position. Insulin aspart was approved for medical use in the United States in 2000. In 2023, it was the 102nd most commonly prescribed medication in the United States, with more than 6 million prescriptions. Manufacturing involves yeast, which have had the gene for insulin aspart put into their genome. This yeast then makes the insulin, which is harvested from the bioreactor. It is on the World Health Organization's List of Essential Medicines.
Medvedev said that if he had not ordered the Russian forces to stop, "Georgia would most likely have a different president by now." On 21 November 2011, Dmitry Medvedev told reporters in Rostov-on-Don, "We have simply calmed some of our neighbors down by showing them that they should behave correctly in respect of Russia and in respect of neighboring small states." He also said that the war was a message to the NATO that "before taking a decision about expansion of the Alliance, one should at first think about the geopolitical stability." On 8 August 2012, Russian Prime Minister Dmitry Medvedev said: "I made my decision two-and-a-half hours after the Georgian army began the active fighting. Not earlier, because this would have been wrong, since this was the decision to use the Armed Forces of the Russian Federation on foreign soil, I underline, the foreign territory. But not later too." He also said that he contacted Putin on 8 August. On 8 August 2012, Russian president Vladimir Putin told journalists that Russia had a plan for the war with Georgia in advance before the hostilities and it was prepared by the Russian General Staff in late 2006-early 2007. According to Putin, he oversaw the plan, which included training of South Ossetian militia. Putin commented on his personal role, "While in Beijing, I called Dmitry Medvedev and the defense minister twice, on August 7 and 8." Putin later said, "The information what was happening at the time of the 5th, 6th, 7th and 8th of the (August 2008), I received directly from Tskhinvali. Oddly enough, from journalists.
Sources: en.wikipedia.org
=== Pro-101-1 (thermal burns) === Pro-101-1 is a topical PDGF-BB gel candidate for the treatment of thermal burns. The company received approval from China's National Medical Products Administration (NMPA) to commence Phase IIa clinical trials in June 2022, which were completed in May 2023. The Phase IIb clinical trial reached last patient out in April 2025, and the clinical report for deep second-degree burns was finalised in December 2025. As of May 2026, Pro-101-1 had enrolled the first patient in its Phase IIIa clinical trial for deep second-degree burns in China. The U.S. FDA has confirmed that Pro-101-1 is eligible for approval via the Section 351(a) biologics BLA pathway.
He sent Signoret specimens of American grape lice, which Signoret concluded – in 1870, while he was besieged in Paris during the Franco-Prussian War – were indeed identical to French grape lice. Meanwhile, Planchon and Lichtenstein had found vines with afflicted leaves; lice that were transferred from those leaves to the roots of healthy vines attached themselves to the vines' roots as other French grape lice did. Also in 1870, Riley discovered that American grape lice wintered on American grape vines' roots, which the insects damaged, albeit less than in the case of French vines. Riley repeated Planchon and Lichtenstein's experiment using American grape vines and American grape lice, with similar results. Thus the identity of the French and American grape lice was proven. Nevertheless, for another three years, a powerful majority in France argued that Phylloxera was not the cause of vine disease; instead, vines that were already sickly became infested with Phylloxera. Thus, in their opinion, Phylloxera was merely a consequence of the "true" disease, which remained to be found. Regardless, Riley had discovered American grape varieties that were especially resistant to Phylloxera, and by 1871, French farmers began to import them and to graft French vines onto the American rootstock. (Leo Laliman had suggested importing American vines as early as 1869, but French farmers were reluctant to abandon their traditional varieties.
22 September It is reported that eight-year-old Aditi Shankar has become the first child in the UK to receive a kidney transplant that will not require her to take medication to prevent the organ being rejected, and that she is healthy and has returned to school. In his first statement since further allegations were made against him, Russell Brand posts a video on social media describing his week as "extraordinary and distressing". 23 September The government's home energy efficiency taskforce is scrapped. Members of the anti-monarchist pressure group Republic stage what they describe as the "first-ever" protest inside Buckingham Palace. 24 September – Home Secretary Suella Braverman orders a review into armed policing, after 300 firearms officers hand in their weapons, following concerns over a police officer charged with murdering 24-year-old Chris Kaba. Most of the officers return to their duties the following day. 25 September A hearing at Manchester Crown Court determines that Lucy Letby will face a retrial for one of the six counts of attempted murder that the jury at her original trial was unable to reach a verdict on; a provisional trial date is set for 10 June 2024. The Metropolitan Police are to investigate allegations of non-recent sexual offences following recent reports about comedian Russell Brand. 26 September Home Secretary Suella Braverman tells a US think tank the 1951 Refugees Convention is no longer fit for the modern age, and that being discriminated against for being gay or female should not be enough to qualify for refugee status.
== Journals == Numerous journals are dedicated to the field of proteomics and related areas. Note that journals dealing with proteins are usually more focused on structure and function while proteomics journals are more focused on the large-scale analysis of whole proteomes or at least large sets of proteins. Some relevant proteomics journals are listed below (with their publishers).
Sources: en.wikipedia.org
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.
It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.
Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.
Mass spectrometry establishes whether the observed molecular weight matches the calculated sequence mass. Chromatographic retention and fragment mapping add further confidence about sequence and composition. A single technique alone is rarely treated as sufficient evidence of identity.